Lisata Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Encouraging results of Cohort A data from the ASCEND trial presented at ASCO-GI 2025;
Cohort B results from the ASCEND trial accepted for an oral presentation at ESMO-GI 2025

Read more at globenewswire.com